Skip to main content
. 2022 Oct 17;75:10–18. doi: 10.1016/j.jelectrocard.2022.10.005

Table 2.

Unweighted and propensity score weighted baseline characteristics.


Unweighted, N = 238

Weighted, N = 238

Variables, mean ± standard deviation Normal ECG
N = 103
Abnormal ECG
N = 135
KS p-value Normal ECG
N = 103
Abnormal ECG
N = 135
KS p-value
Age (years) 58 ± 15 65 ± 16 0.0050 59 ± 15 63 ± 16 0.22
Male sex (binary) 0.74 ± 0.44 0.73 ± 0.44 0.94 0.73 ± 0.45 0.75 ± 0.45 0.68
BMI 28 ± 6.6 27 ± 5.1 0.45 28 ± 6.4 27 ± 5.1 0.69



Comorbidities (binary, yes)
 Diabetes 0.17 ± 0.37 0.27 ± 0.45 0.048 0.16 ± 0.37 0.26 ± 0.44 0.072
 Hypertension 0.36 ± 0.48 0.53 ± 0.50 0.011 0.37 ± 0.48 0.50 ± 0.50 0.061
 Hyperlipidemia 0.13 ± 0.33 0.19 ± 0.39 0.17 0.13 ± 0.34 0.13 ± 0.39 0.31
 IHD 0.068 ± 0.25 0.16 ± 0.36 0.040 0.079 ± 0.27 0.14 ± 0.35 0.16
 Prior AMI 0.058 ± 0.23 0.11 ± 0.31 0.16 0.067 ± 0.25 0.10 ± 0.31 0.35
 Prior stroke 0.087 ± 0.28 0.17 ± 0.38 0.065 0.10 ± 0.30 0.15 ± 0.35 0.30
 Prior VTE 0.039 ± 0.19 0.059 ± 0.24 0.48 0.038 ± 0.19 0.061 ± 0.24 0.43
 HFrEF 0.019 ± 0.14 0.052 ± 0.22 0.20 0.024 ± 0.15 0.047 ± 0.21 0.37
 HFpEF 0 0.037 ± 0.19 0.048 0 0.032 ± 0.18 0.036
 History of AF 0.068 ± 0.25 0.19 ± 0.39 0.0060 0.077 ± 0.27 0.17 ± 0.37 0.048
 Peripheral artery disease 0 0.022 ± 0.15 0.13 0 0.022 ± 0.15 0.10
 COPD 0.049 ± 0.22 0.059 ± 0.24 0.72 0.051 ± 0.22 0.056 ± 0.23 0.85
 Astma 0.068 ± 0.25 0.052 ± 0.22 0.60 0.062 ± 0.24 0.055 ± 0.23 0.80
 CKD 0.01 ± 0.10 0.089 ± 0.29 0.0080 0.011 ± 0.10 0.073 ± 0.26 0.030
 Active cancera 0.039 ± 0.19 0.059 ± 0.24 0.48 0.047 ± 0.21 0.058 ± 0.23 0.72
 Any dementiab 0.019 ± 0.14 0.037 ± 0.19 0.43 0.024 ± 0.15 0.037 ± 0.19 0.62
 Smokingc 0.53 ± 0.50 0.56 ± 0.50 0.88 0.54 ± 0.50 0.55 ± 0.50 0.99



Medication at admission (yes)
 Beta-blockers 0.18 ± 0.38 0.33 ± 0.47 0.0090 0.20 ± 0.40 0.30 ± 0.46 0.084
 Anti-arrhythmic agentd 0 0.015 ± 0.12 0.22 0 0.011 ± 0.10 0.19
 Digoxin 0 0.022 ± 0.15 0.13 0 0.021 ± 0.14 0.11
 Aspirin 0.068 ± 0.25 0.15 ± 0.36 0.055 0.077 ± 0.27 0.14 ± 0.35 0.14
 Warfarin 0.01 ± 0.098 0.037 ± 0.19 0.19 0.0080 ± 0.088 0.033 ± 0.18 0.15
 DOAC 0.068 ± 0.25 0.15 ± 0.36 0.055 0.079 ± 0.27 0.13 ± 0.34 0.21
 ACE inhibitor 0.17 ± 0.37 0.24 ± 0.43 0.14 0.17 ± 0.38 0.23 ± 0.42 0.26
 ARB 0.12 ± 0.32 0.13 ± 0.34 0.70 0.12 ± 0.33 0.13 ± 0.33 0.91
 Calcium antagonist 0.17 ± 0.37 0.20 ± 0.40 0.49 0.17 ± 0.38 0.19 ± 0.40 0.71
 Statins 0.21 ± 0.41 0.33 ± 0.47 0.057 0.23 ± 0.42 0.30 ± 0.46 0.24
 P2Y12 inhibitor 0.019 ± 0.14 0.096 ± 0.30 0.017 0.022 ± 0.15 0.083 ± 0.28 0.058
 MRA 0.029 ± 0.17 0.022 ± 0.15 0.74 0.033 ± 0.18 0.021 ± 0.14 0.57
 Diuretics 0.058 ± 0.23 0.17 ± 0.38 0.010 0.068 ± 0.25 0.15 ± 0.36 0.061
 Oral antidiabetics 0.15 ± 0.35 0.22 ± 0.41 0.18 0.14 ± 0.35 0.20 ± 0.40 0.22
 Oral cortisone 0.049 ± 0.22 0.059 ± 0.24 0.72 0.056 ± 0.23 0.052 ± 0.22 0.90



Symptoms and signs at admission
 Systolic BP (mmHg) 126 ± 21 128 ± 22 0.69 126 ± 21 127 ± 22 0.81
 Diastolic BP (mmHg) 77 ± 13 75 ± 13 0.24 77 ± 13 76 ± 13 0.58
 Heart rate (bpm) 95 ± 18 100 ± 23 0.13 95 ± 18 99 ± 22 0.45
 Respiratory rate (brpm) 27 ± 8.4 26 ± 8.0 0.96 27 ± 8.2 26 ± 8.0 0.96
 Saturation no oxygen % 88 ± 8.2 88 ± 12 0.37 88 ± 8.6 88 ± 11 0.87
 Oxygen at admission % (n/N)e 0.76 ± 0.43 0.67 ± 0.47 0.13 0.74 ± 0.44 0.68 ± 0.47 0.30
 Ct value (cycles) 28 ± 5.7 27 ± 5.9 0.35 27 ± 5.7 27 ± 5.6 0.65
 Fever % (n/N)f 0.64 ± 0.48 0.58 ± 0.49 0.33 0.63 ± 0.48 0.58 ± 0.49 0.43
 Cough 0.82 ± 0.39 0.77 ± 0.42 0.40 0.80 ± 0.40 0.78 ± 0.42 0.66
 Dyspnea 0.70 ± 0.46 0.68 ± 0.47 0.77 0.69 ± 0.46 0.68 ± 0.47 0.81
 Sore throat 0.16 ± 0.36 0.13 ± 0.33 0.52 0.15 ± 0.35 0.14 ± 0.34 0.83
 Nasal congestion 0.019 ± 0.14 0.037 ± 0.19 0.43 0.022 ± 0.15 0.031 ± 0.17 0.688
 Loss of smell 0.12 ± 0.32 0.044 ± 0.21 0.039 0.10 ± 0.30 0.048 ± 0.21 0.11
 Loss of taste 0.097 ± 0.30 0.052 ± 0.22 0.18 0.083 ± 0.28 0.059 ± 0.24 0.47
 Headache 0.12 ± 0.32 0.089 ± 0.29 0.49 0.11 ± 0.32 0.092 ± 0.29 0.58
 Chest pain 0.16 ± 0.36 0.074 ± 0.26 0.048 0.14 ± 0.35 0.080 ± 0.27 0.13
 Abdominal pain 0.039 ± 0.19 0.030 ± 0.17 0.70 0.040 ± 0.20 0.029 ± 0.17 0.65
 Vomiting 0.087 ± 0.28 0.074 ± 0.26 0.71 0.087 ± 0.28 0.072 ± 0.26 0.68
 Diarrhea 0.18 ± 0.38 0.11 ± 0.31 0.16 0.17 ± 0.37 0.12 ± 0.32 0.28
 Disorientationg 0.058 ± 0.23 0.13 ± 0.34 0.058 0.077 ± 0.27 0.12 ± 0.32 0.33

ECG = electrocardiogram; KS = Kolmogorov-Smirnov; BMI = body mass index; IHD = ischemic heart disease; AMI = acute myocardial infarction; VTE = venous thromboembolism: HFrEF = heart failure reduced ejection fraction; HFpEF = heart failure preserved ejection fraction; AF = atrial fibrillation; COPD = chronic obstructive pulmonary disease; CKD = chronic kidney disease; DOAC = Direct-acting oral anticoagulant; ACE = angiotensin-converting enzyme; ARB = angiotensin receptor blocker; MRA = mineralocorticoid receptor antagonist; BP = blood pressure; bpm = beats per minute; brpm = breaths per minute; Ct value = cycle threshold value.

a

Any active cancer.

b

Any dementia diagnosis prior to admission; ccurrent or ex-smoker; dNon beta-blocker anti-arrhythmic medication.

e

Treated with oxygen or not treated with oxygen at admission.

f

Body temperature ≥ 38 degrees Celsius.

g

New disorientation aggravated previous disorientation.